Mingbin Zheng

7.8k total citations · 5 hit papers
77 papers, 6.8k citations indexed

About

Mingbin Zheng is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Mingbin Zheng has authored 77 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Biomedical Engineering, 24 papers in Biomaterials and 19 papers in Molecular Biology. Recurrent topics in Mingbin Zheng's work include Nanoplatforms for cancer theranostics (40 papers), Nanoparticle-Based Drug Delivery (24 papers) and RNA Interference and Gene Delivery (9 papers). Mingbin Zheng is often cited by papers focused on Nanoplatforms for cancer theranostics (40 papers), Nanoparticle-Based Drug Delivery (24 papers) and RNA Interference and Gene Delivery (9 papers). Mingbin Zheng collaborates with scholars based in China, Iran and United States. Mingbin Zheng's co-authors include Lintao Cai, Yifan Ma, Pengfei Zhao, Zonghai Sheng, Ping Gong, Zhenyu Luo, Pengfei Zhang, Ai-Qing Ma, Lanlan Liu and Cuifang Zheng and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomaterials.

In The Last Decade

Mingbin Zheng

74 papers receiving 6.8k citations

Hit Papers

Cancer Cell Membrane–Biomimetic Nanoparticles for Homolog... 2013 2026 2017 2021 2016 2013 2014 2018 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingbin Zheng China 37 5.4k 2.2k 1.9k 1.8k 1.2k 77 6.8k
Yiqiao Hu China 46 4.8k 0.9× 1.9k 0.9× 2.0k 1.1× 1.9k 1.1× 1.5k 1.3× 144 7.8k
Chu‐Xin Li China 33 4.8k 0.9× 1.4k 0.6× 1.5k 0.8× 2.4k 1.4× 1.0k 0.9× 52 6.0k
Xiaoqi Sun China 33 4.6k 0.9× 1.9k 0.8× 2.0k 1.0× 1.9k 1.1× 919 0.8× 70 6.8k
Ping Gong China 39 4.4k 0.8× 1.7k 0.8× 1.9k 1.0× 2.3k 1.3× 944 0.8× 138 6.3k
Heebeom Koo South Korea 52 4.6k 0.9× 3.5k 1.6× 3.6k 1.9× 1.9k 1.1× 1.0k 0.9× 119 9.2k
Guangbao Yang China 35 5.5k 1.0× 2.4k 1.1× 1.5k 0.8× 3.7k 2.1× 1.1k 0.9× 53 7.5k
Wen‐Xiu Qiu China 37 4.2k 0.8× 1.9k 0.8× 1.7k 0.9× 2.0k 1.1× 947 0.8× 58 5.4k
Zhenyu Luo China 28 3.6k 0.7× 1.3k 0.6× 1.4k 0.7× 1.2k 0.7× 913 0.8× 85 5.1k
Wei Tang China 48 5.9k 1.1× 2.3k 1.0× 2.0k 1.0× 4.2k 2.3× 1.3k 1.1× 105 8.8k
Rui Tian China 46 6.2k 1.1× 2.0k 0.9× 2.5k 1.3× 3.6k 2.0× 1.3k 1.1× 99 9.1k

Countries citing papers authored by Mingbin Zheng

Since Specialization
Citations

This map shows the geographic impact of Mingbin Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingbin Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingbin Zheng more than expected).

Fields of papers citing papers by Mingbin Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingbin Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingbin Zheng. The network helps show where Mingbin Zheng may publish in the future.

Co-authorship network of co-authors of Mingbin Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingbin Zheng. A scholar is included among the top collaborators of Mingbin Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingbin Zheng. Mingbin Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Zhiqiang, Zhiqiang Song, Hong Yu, et al.. (2025). Ultra-sensitive in situ detection of intracellular Mycobacterium tuberculosis with CRISPR/Cas12a. Frontiers in Immunology. 16. 1597654–1597654. 1 indexed citations
2.
Zhou, Luyi, et al.. (2024). Current status and prospects of detection of breast cancer by MOFs platform. Journal of Molecular Structure. 1321. 139797–139797. 8 indexed citations
3.
Yin, Ting, Cuiping Zeng, Hong Pan, et al.. (2024). Cryomicroneedle delivery of nanogold-engineered Rhodospirillum rubrum for photochemical transformation and tumor optical biotherapy. Bioactive Materials. 37. 505–516. 10 indexed citations
4.
Liu, Yong, Junzhang Zhao, Baoxiang Huang, et al.. (2024). Identification and validation of an immunotherapeutic signature for colon cancer based on the regulatory patterns of ferroptosis and their association with the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(5). 119698–119698. 3 indexed citations
5.
Zhao, Pengfei, Xiangke Duan, Qianting Yang, et al.. (2023). Devising novel near-infrared aggregation-induced-emission luminogen labeling for point-of-care diagnosis of <i>Mycobacterium tuberculosis </i>. BioScience Trends. 17(3). 234–238. 7 indexed citations
6.
Liao, Donghui, et al.. (2023). Current status of Fe-based MOFs in biomedical applications. RSC Medicinal Chemistry. 14(12). 2473–2495. 24 indexed citations
8.
Zhang, Baozhen, Hong Pan, Ze Chen, et al.. (2023). Twin-bioengine self-adaptive micro/nanorobots using enzyme actuation and macrophage relay for gastrointestinal inflammation therapy. Science Advances. 9(8). eadc8978–eadc8978. 60 indexed citations
9.
Liao, Donghui, Jiefeng Huang, Chenyi Jiang, et al.. (2023). A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies. Pharmaceutics. 15(8). 2071–2071. 31 indexed citations
10.
Zhao, Pengfei, Shuo Song, Deliang Liu, et al.. (2023). Development of a novel cholesterol tag-based system for trans-membrane transport of protein drugs. BioScience Trends. 17(6). 503–507.
11.
Luo, Yingmei, Ze Chen, Mingjian Sun, et al.. (2021). IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy. Biomaterials. 281. 121341–121341. 91 indexed citations
12.
He, Huamei, Lanlan Liu, Shengping Zhang, et al.. (2020). Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance. Journal of Controlled Release. 323. 387–397. 46 indexed citations
13.
Gao, Rongkang, Hao Xu, Liangjian Liu, et al.. (2020). Photoacoustic visualization of the fluence rate dependence of photodynamic therapy. Biomedical Optics Express. 11(8). 4203–4203. 10 indexed citations
14.
Zhang, Baozhen, Mingbin Zheng, Lintao Cai, & Xiujun Fan. (2018). Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles. Journal of Visualized Experiments. 10 indexed citations
15.
Zhao, Pengfei, Mingbin Zheng, Zhenyu Luo, et al.. (2015). NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy. Scientific Reports. 5(1). 14258–14258. 87 indexed citations
16.
Zhao, Pengfei, Mingbin Zheng, Caixia Yue, et al.. (2014). Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles. Biomaterials. 35(23). 6037–6046. 184 indexed citations
17.
Yue, Caixia, Peng Liu, Mingbin Zheng, et al.. (2013). IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials. 34(28). 6853–6861. 336 indexed citations
18.
Gong, Ping, Bihua Shi, Pengfei Zhang, et al.. (2012). DNase-activatable fluorescence probes visualizing the degradation of exogenous DNA in living cells. Nanoscale. 4(7). 2454–2454. 12 indexed citations
19.
Zheng, Cuifang, Mingbin Zheng, Ping Gong, et al.. (2012). Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging. Biomaterials. 33(22). 5603–5609. 241 indexed citations
20.
Wu, Ping, Xiaoxiao He, Kemin Wang, et al.. (2009). A Novel Methotrexate Delivery System Based on Chitosan-Methotrexate Covalently Conjugated Nanoparticles. Journal of Biomedical Nanotechnology. 5(5). 557–564. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026